Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 21, 2006
Developing therapeutics for schizophrenia and other psychotic disordersGerard Marek, Kalpana Merchant
Nature Communications|December 6, 2019
LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson's disease patientsDaniel Ysselstein, Maria Nguyen, Tiffany J Young, et al.
Journal of Parkinson'S Disease|April 17, 2023
Proposal for a Biologic Staging System of Parkinson's DiseaseLana M Chahine, Kalpana Merchant, Andrew Siderowf, et al.
Neurobiology of Disease|May 11, 2005
Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without L-DOPA administrationDiane T Stephenson, Qiu Li, Carol Simmons, et al.
Disease Models & Mechanisms|December 21, 2022
Collaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemicMaria Isabel Loza, Julija Hmeljak, Chas Bountra, et al.
EMBO Molecular Medicine|January 22, 2021
Urinary proteome profiling for stratifying patients with familial Parkinson's diseaseSebastian Virreira Winter, Ozge Karayel, Maximilian T Strauss, et al.
The Journal of Biological Chemistry|January 10, 2026
A luminescent reporter assay to quantify SORL1 ectodomain shedding and Retromer-dependent endosome recycling activityElnaz Fazeli, Asad Jan, Ann-Kathrin Huber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2019
Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic DevelopmentRoy N Alcalay, Frank Hsieh, Elizabeth Tengstrand, et al.
Science Advances|April 2, 2025
Alpha-synuclein seed amplification assays: Data sharing, standardization needed for clinical useHilal A Lashuel, D James Surmeier, Tanya Simuni, et al.
Scientific Reports|July 24, 2014
Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometryJohn F Kellie, Richard E Higgs, John W Ryder, et al.
Pageof 5